News
DealMonitor: 468 invests in Gauss Robotics – Exazyme secures €2 million – D2C Angels bet on ingarden
Exazyme secures €2 million investment from AIX Ventures and Atlantic Labs. As a Berlin-based AI-Biotech startup, founded in 2022 by Ingmar Schuster, Philipp Markert, and Dr. Jelena Ivanovska, we leverage AI-based solutions to identify the optimal protein variations for diverse applications. Through training the AI with datasets, the team predicts the properties of novel protein variants.
Read full article here: https://www.deutsche-startups.de/2023/05/15/dealmonitor-gauss-robotics-exazyme/
DEUTSCHE STARTUPS, 15. Mai 2023
More from Exazyme
- News/
Exazyme partners with Ginkgo Bioworks and becomes part of the Ginkgo Technology Network
Exazyme partners with Ginkgo Bioworks, joining the Ginkgo Technology Network to empower R&D teams with AI-driven protein engineering solutions.
Read More
- Knowledge/
Painful Intelligence: Aapo Hyvärinen on the Concept of Suffering, Drawing Parallels between Humans and AI, and Conclusions for AI Ethics.
Explore Dr. Aapo Hyvärinen’s perspective on the concept of suffering, the parallels between humans and AI, and potential conclusion for AI ethics.
Read More